Literature DB >> 2988021

Double bond requirement for the 5-lipoxygenase pathway.

Y F Wei, R W Evans, A R Morrison, H Sprechert, B A Jakschik.   

Abstract

We showed previously that polyenoic fatty acids with double bonds at carbon 5,8,11 are good substrates for the 5-lipoxygenase and also can be converted to LTC and dihydroxy acids. In order to determine whether all three double bonds are necessary for the 5-lipoxygenase-leukotriene pathway we studied 5,8,14-eicosatrienoic and 5,11,14-eicosatrienoic acid. C14-labeled fatty acids were incubated with 10,000 X g supernatant of homogenate of rat basophilic leukemia (RBL-1) cells in the presence of Ca++ at 37 degrees C. 5,11,14-Eicosatrienoic acid was not converted by the 5-lipoxygenase pathway and 5,8,14-eicosatrienoic acid was mainly converted to 5-hydroxy-6,8,14-eicosatrienoic acid (5-HETE). This monohydroxy was identified by UV spectrometry (UV max 235 nm) and GC-mass spectrometry. Incubations with whole homogenate analyzed by HPLC and bioassay showed that no detectable LTC, LTD or LTE was formed. These data indicate that fatty acids which have double bonds at carbon 5 and carbon 8 are readily converted to the 5-hydroperoxide. However double bonds at carbon 5,8 and 11 are necessary for LTA biosynthesis. This study therefore extends the characterization of the double bond requirement of the 5-lipoxygenase-leukotriene pathway. The number of double bonds necessary at each step varies and increases with each step in the pathway.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2988021     DOI: 10.1016/0090-6980(85)90078-4

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  2 in total

Review 1.  The eosinophil chemoattractant 5-oxo-ETE and the OXE receptor.

Authors:  William S Powell; Joshua Rokach
Journal:  Prog Lipid Res       Date:  2013-09-19       Impact factor: 16.195

2.  FADS2 function loss at the cancer hotspot 11q13 locus diverts lipid signaling precursor synthesis to unusual eicosanoid fatty acids.

Authors:  Woo Jung Park; Kumar S D Kothapalli; Peter Lawrence; J Thomas Brenna
Journal:  PLoS One       Date:  2011-11-30       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.